Heberprovac

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHeberprovac
Drug Alias NameGnRHm1-TTtherapeutic peptide subunit vaccine (prostate cancer)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Toxoid vaccine
Mechanisms of ActionGonadotropin-releasing hormone modulators
TargetsGonadotropin-releasing hormone
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesCenter For Genetic Engineering And Biotechnology
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A